II. CLINICAL MANIFESTATIONS
A. Degenerative diseases.
1. Cortical dementia.
a. AD is characterized by two principal features—the neurofibrillary tangle and the neuritic plaque. Early in the course of the disease, the entorhinal cortex, which is a pivotal way station for input to and from the hippocampus, is disrupted by neurofibrillary tangles in cortical layers II and IV. The perforant pathway, which is the main route for entry into the hippocampal formation, is gradually and massively demyelinated. The hippocampus eventually is almost deafferentated from cortical input. AD also breaks down the efferent linkage of the hippocampus back to the cerebral cortex through destruction of the subiculum and entorhinal cortex. The hallmark behavioral sign of this destruction is amnesia—specifically, an anterograde (learning) defect that covers declarative knowledge but largely spares nondeclarative learning and retrieval. Early in the course of the disease, retrograde memory is relatively spared, but as the pathologic process extends to nonmesial temporal sectors, a defect in the retrograde compartment (retrieval impairment) appears and gradually worsens.
b. Pick’s disease, characterized by Pick bodies (cells containing degraded protein material), is an uncommon form of cortical dementia that often shows a striking predilection for one lobe of the brain, producing a state of circumscribed lobar atrophy. The disease often is concentrated in the frontal lobes, in which case personality alterations as well as compromised judgment and problem solving, rather than amnesia, are the prominent manifestations. However, the disease can affect one or the other temporal lobe and produce signs of a material-specific amnesia.
c. Frontal lobe dementia is another form of cortical dementia. It involves focal atrophy of the frontal lobes, which causes personality changes and other signs of executive dysfunction. This condition is similar to Pick’s disease, except there is no predominance of Pick bodies.
d. Frontotemporal dementia is characterized by symmetric atrophy of the frontal and temporal lobes. The earliest and most prominent cognitive symptoms involve personality and behavioral changes. Although reports of memory problems are common in frontotemporal dementia, they are never the sole or dominating feature. Severe amnesia is considered an exclusionary criterion. Memory functioning is described as selective (e.g., “she remembers what she wants to remember”). Knowledge regarding orientation and current autobiographical events remains largely preserved.
2. Subcortical dementia.
a. Parkinson’s disease is focused in subcortical structures and influences memory in a manner different from cortical forms of dementia such as AD and Pick’s disease. Disorders of nondeclarative memory (e.g., acquisition and retrieval of motor skills) are more prominent, and there may be minimal or no impairment in learning of declarative material. Patients with Parkinson’s disease often have more problems in recall of newly acquired knowledge than in storage. When cuing strategies are provided, the patients have normal levels of retention.
b. Huntington’s disease is also concentrated in subcortical structures and amnesia of patients with Huntington’s disease resembles that of patients with Parkinson’s disease. In particular, there is disproportionate involvement of nondeclarative memory. Patients with Huntington’s disease also tend to have disruption of working memory.
c. Progressive supranuclear palsy is another primarily subcortical disease process that frequently produces problems with memory. In general, however, the associated amnesia is considerably less severe than that of AD. Laboratory assessment often shows relatively mild defects in learning and retrieval despite the patient’s reports of forgetfulness.
3. Other degenerative conditions.
a. Dementia related to Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) is notable for varying degrees of memory impairment, with severity being roughly proportional to disease progression. Early in the course, memory defects may be the sole signs of cognitive dysfunction. The problems center on the acquisition of new material, particularly material of the declarative type. Memory defects in this disease appear to be attributable mainly to defective attention, concentration, and overall efficiency of cognitive functioning rather than to focal dysfunction of memory-related neural systems. Various investigators have found that the rate of percentage of CD4 lymphocyte cell loss is associated with and may represent a risk factor for cognitive dysfunction among persons with HIV/AIDS.
b. Multiple sclerosis (MS) patients have varying degrees of amnesia, although the severity can wax and wane considerably in concert with other neurologic symptoms. Many patients with MS have no memory defects during some periods of the disease. When present, the memory impairment most commonly manifests as defective recall of newly learned information. Encoding and working memory are normal or near-normal. Patients with MS often benefit from cuing. The amnesia of MS usually affects declarative material of both verbal and nonverbal types; defects in nondeclarative memory are rare.